![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/05/21/2885664/0/en/Sana-Biotechnology-Highlights-Publication-in-Nature-Biotechnology-of-Novel-In-Vivo-Preclinical-Data-Showing-the-Potential-for-Pluripotent-Stem-Cell-Derived-Human-Glial-Progenitor-C.html
https://www.globenewswire.com/news-release/2024/05/08/2878206/0/en/Sana-Biotechnology-Reports-First-Quarter-2024-Financial-Results-and-Business-Updates.html
https://www.globenewswire.com/news-release/2024/05/06/2876143/0/en/Sana-Biotechnology-to-Present-at-May-and-June-2024-Investor-Conferences.html
https://ir.sana.com/news-releases/news-release-details/sana-biotechnology-reports-fourth-quarter-and-full-year-2023
https://www.globenewswire.com//news-release/2024/02/28/2837405/0/en/Sana-Biotechnology-to-Present-at-the-Cowen-44th-Annual-Health-Care-Conference.html
https://www.fiercebiotech.com/research/sanas-engineered-pancreatic-islet-cells-control-blood-sugar-monkey-model-type-1-diabetes
https://www.globenewswire.com//news-release/2024/02/13/2828638/0/en/Sana-Biotechnology-Announces-Publication-of-Preclinical-Diabetes-Data-in-Cell-Stem-Cell-Demonstrating-Insulin-Independence-Following-Transplantation-of-Hypoimmune-Allogeneic-Primar.html
https://www.globenewswire.com//news-release/2024/02/12/2827865/0/en/Sana-Biotechnology-Announces-Closing-of-Upsized-Public-Offering-and-Full-Exercise-of-Underwriters-Option-to-Purchase-Additional-Shares.html
https://www.globenewswire.com//news-release/2024/02/08/2825690/0/en/Sana-Biotechnology-Announces-Pricing-of-Upsized-Public-Offering.html
https://www.globenewswire.com//news-release/2024/02/07/2825536/0/en/Sana-Biotechnology-Announces-Proposed-Public-Offering-of-Common-Stock.html